カテゴリ： 世界, 医療/バイオ, QYResearch

膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他

■ 英語タイトル：Global Pancreatic Cancer Metastasis Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA6458）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA6458
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：85
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は膵臓がん転移治療のグローバル市場について調査・分析し、世界の膵臓がん転移治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（化学療法、標的療法、その他）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Lilly、Merck、Celgene、BioLineRx、AstraZeneca、Roche、Amgen、Pfizer、Nantkwest, Incなどが含まれています。膵臓がん転移治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、膵臓がん転移治療市場規模を算出する際に考慮しました。

・膵臓がん転移治療市場の概要
- 膵臓がん転移治療の種類別セグメント
- 世界の膵臓がん転移治療市場規模：タイプ別分析（化学療法、標的療法、その他）
- 膵臓がん転移治療の用途別セグメント
- 世界の膵臓がん転移治療市場規模：用途別分析（病院、クリニック、その他）
- 世界の膵臓がん転移治療市場規模予測（2018年-2029年）

・膵臓がん転移治療市場の成長トレンド
- 膵臓がん転移治療の地域別市場規模（2018年-2029年）
- 膵臓がん転移治療市場ダイナミクス
- 膵臓がん転移治療の業界動向
- 膵臓がん転移治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：化学療法、標的療法、その他
- 世界の膵臓がん転移治療のタイプ別市場規模（2018年-2023年）
- 世界の膵臓がん転移治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック、その他
- 世界の膵臓がん転移治療の用途別市場規模（2018年-2023年）
- 世界の膵臓がん転移治療の用途別市場規模（2024年-2029年）

・膵臓がん転移治療の地域別市場規模
- 北米の膵臓がん転移治療市場規模（2018年-2029年）
- 米国の膵臓がん転移治療市場規模（2018年-2029年）
- ヨーロッパの膵臓がん転移治療市場規模（2018年-2029年）
- アジア太平洋の膵臓がん転移治療市場規模（2018年-2029年）
- 中国の膵臓がん転移治療市場規模（2018年-2029年）
- 日本の膵臓がん転移治療市場規模（2018年-2029年）
- 韓国の膵臓がん転移治療市場規模（2018年-2029年）
- インドの膵臓がん転移治療市場規模（2018年-2029年）
- オーストラリアの膵臓がん転移治療市場規模（2018年-2029年）
- 中南米の膵臓がん転移治療市場規模（2018年-2029年）
- 中東・アフリカの膵臓がん転移治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Lilly、Merck、Celgene、BioLineRx、AstraZeneca、Roche、Amgen、Pfizer、Nantkwest, Inc

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Pancreatic Cancer Metastasis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Pancreatic Cancer Metastasis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Pancreatic Cancer Metastasis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Pancreatic Cancer Metastasis Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Pancreatic Cancer Metastasis Treatment include Lilly, Merck, Celgene, BioLineRx, AstraZeneca, Roche, Amgen, Pfizer and Nantkwest, Inc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pancreatic Cancer Metastasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatic Cancer Metastasis Treatment.
The Pancreatic Cancer Metastasis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pancreatic Cancer Metastasis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pancreatic Cancer Metastasis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Lilly
Merck
Celgene
BioLineRx
AstraZeneca
Roche
Amgen
Pfizer
Nantkwest, Inc
Segment by Type
Chemotherapy
Targeted Therapy
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pancreatic Cancer Metastasis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pancreatic Cancer Metastasis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Cancer Metastasis Treatment Market Perspective (2018-2029)
2.2 Pancreatic Cancer Metastasis Treatment Growth Trends by Region
2.2.1 Global Pancreatic Cancer Metastasis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pancreatic Cancer Metastasis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Pancreatic Cancer Metastasis Treatment Market Dynamics
2.3.1 Pancreatic Cancer Metastasis Treatment Industry Trends
2.3.2 Pancreatic Cancer Metastasis Treatment Market Drivers
2.3.3 Pancreatic Cancer Metastasis Treatment Market Challenges
2.3.4 Pancreatic Cancer Metastasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Cancer Metastasis Treatment Players by Revenue
3.1.1 Global Top Pancreatic Cancer Metastasis Treatment Players by Revenue (2018-2023)
3.1.2 Global Pancreatic Cancer Metastasis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Pancreatic Cancer Metastasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Cancer Metastasis Treatment Revenue
3.4 Global Pancreatic Cancer Metastasis Treatment Market Concentration Ratio
3.4.1 Global Pancreatic Cancer Metastasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Cancer Metastasis Treatment Revenue in 2022
3.5 Pancreatic Cancer Metastasis Treatment Key Players Head office and Area Served
3.6 Key Players Pancreatic Cancer Metastasis Treatment Product Solution and Service
3.7 Date of Enter into Pancreatic Cancer Metastasis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Cancer Metastasis Treatment Breakdown Data by Type
4.1 Global Pancreatic Cancer Metastasis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Type (2024-2029)
5 Pancreatic Cancer Metastasis Treatment Breakdown Data by Application
5.1 Global Pancreatic Cancer Metastasis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
6.2 North America Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
6.4 North America Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
7.2 Europe Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
7.4 Europe Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
9.2 Latin America Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
9.4 Latin America Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lilly
11.1.1 Lilly Company Detail
11.1.2 Lilly Business Overview
11.1.3 Lilly Pancreatic Cancer Metastasis Treatment Introduction
11.1.4 Lilly Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.1.5 Lilly Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Pancreatic Cancer Metastasis Treatment Introduction
11.2.4 Merck Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Pancreatic Cancer Metastasis Treatment Introduction
11.3.4 Celgene Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.3.5 Celgene Recent Development
11.4 BioLineRx
11.4.1 BioLineRx Company Detail
11.4.2 BioLineRx Business Overview
11.4.3 BioLineRx Pancreatic Cancer Metastasis Treatment Introduction
11.4.4 BioLineRx Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.4.5 BioLineRx Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Pancreatic Cancer Metastasis Treatment Introduction
11.5.4 AstraZeneca Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.5.5 AstraZeneca Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Pancreatic Cancer Metastasis Treatment Introduction
11.6.4 Roche Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Amgen
11.7.1 Amgen Company Detail
11.7.2 Amgen Business Overview
11.7.3 Amgen Pancreatic Cancer Metastasis Treatment Introduction
11.7.4 Amgen Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.7.5 Amgen Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Pancreatic Cancer Metastasis Treatment Introduction
11.8.4 Pfizer Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.8.5 Pfizer Recent Development
11.9 Nantkwest, Inc
11.9.1 Nantkwest, Inc Company Detail
11.9.2 Nantkwest, Inc Business Overview
11.9.3 Nantkwest, Inc Pancreatic Cancer Metastasis Treatment Introduction
11.9.4 Nantkwest, Inc Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
11.9.5 Nantkwest, Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Others
Table 5. Global Pancreatic Cancer Metastasis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Pancreatic Cancer Metastasis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Pancreatic Cancer Metastasis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Pancreatic Cancer Metastasis Treatment Market Share by Region (2018-2023)
Table 9. Global Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Pancreatic Cancer Metastasis Treatment Market Share by Region (2024-2029)
Table 11. Pancreatic Cancer Metastasis Treatment Market Trends
Table 12. Pancreatic Cancer Metastasis Treatment Market Drivers
Table 13. Pancreatic Cancer Metastasis Treatment Market Challenges
Table 14. Pancreatic Cancer Metastasis Treatment Market Restraints
Table 15. Global Pancreatic Cancer Metastasis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Pancreatic Cancer Metastasis Treatment Market Share by Players (2018-2023)
Table 17. Global Top Pancreatic Cancer Metastasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Cancer Metastasis Treatment as of 2022)
Table 18. Ranking of Global Top Pancreatic Cancer Metastasis Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Pancreatic Cancer Metastasis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pancreatic Cancer Metastasis Treatment Product Solution and Service
Table 22. Date of Enter into Pancreatic Cancer Metastasis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pancreatic Cancer Metastasis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Pancreatic Cancer Metastasis Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Pancreatic Cancer Metastasis Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Pancreatic Cancer Metastasis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Pancreatic Cancer Metastasis Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Pancreatic Cancer Metastasis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Pancreatic Cancer Metastasis Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Lilly Company Detail
Table 48. Lilly Business Overview
Table 49. Lilly Pancreatic Cancer Metastasis Treatment Product
Table 50. Lilly Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 51. Lilly Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck Pancreatic Cancer Metastasis Treatment Product
Table 55. Merck Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Celgene Company Detail
Table 58. Celgene Business Overview
Table 59. Celgene Pancreatic Cancer Metastasis Treatment Product
Table 60. Celgene Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 61. Celgene Recent Development
Table 62. BioLineRx Company Detail
Table 63. BioLineRx Business Overview
Table 64. BioLineRx Pancreatic Cancer Metastasis Treatment Product
Table 65. BioLineRx Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 66. BioLineRx Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Pancreatic Cancer Metastasis Treatment Product
Table 70. AstraZeneca Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Roche Company Detail
Table 73. Roche Business Overview
Table 74. Roche Pancreatic Cancer Metastasis Treatment Product
Table 75. Roche Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Amgen Company Detail
Table 78. Amgen Business Overview
Table 79. Amgen Pancreatic Cancer Metastasis Treatment Product
Table 80. Amgen Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Pfizer Company Detail
Table 83. Pfizer Business Overview
Table 84. Pfizer Pancreatic Cancer Metastasis Treatment Product
Table 85. Pfizer Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. Nantkwest, Inc Company Detail
Table 88. Nantkwest, Inc Business Overview
Table 89. Nantkwest, Inc Pancreatic Cancer Metastasis Treatment Product
Table 90. Nantkwest, Inc Revenue in Pancreatic Cancer Metastasis Treatment Business (2018-2023) & (US$ Million)
Table 91. Nantkwest, Inc Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Cancer Metastasis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pancreatic Cancer Metastasis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Others Features
Figure 6. Global Pancreatic Cancer Metastasis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Pancreatic Cancer Metastasis Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Pancreatic Cancer Metastasis Treatment Report Years Considered
Figure 12. Global Pancreatic Cancer Metastasis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Pancreatic Cancer Metastasis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Pancreatic Cancer Metastasis Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Pancreatic Cancer Metastasis Treatment Market Share by Players in 2022
Figure 16. Global Top Pancreatic Cancer Metastasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pancreatic Cancer Metastasis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pancreatic Cancer Metastasis Treatment Revenue in 2022
Figure 18. North America Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Pancreatic Cancer Metastasis Treatment Market Share by Country (2018-2029)
Figure 20. United States Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pancreatic Cancer Metastasis Treatment Market Share by Country (2018-2029)
Figure 24. Germany Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pancreatic Cancer Metastasis Treatment Market Share by Region (2018-2029)
Figure 32. China Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pancreatic Cancer Metastasis Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pancreatic Cancer Metastasis Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Pancreatic Cancer Metastasis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Lilly Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 48. Celgene Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 49. BioLineRx Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 52. Amgen Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 53. Pfizer Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 54. Nantkwest, Inc Revenue Growth Rate in Pancreatic Cancer Metastasis Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 黄体形成ホルモン放出拮抗薬のグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他
  • セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法
  • 放射線塞栓術がん治療の世界市場2023年：経動脈的放射線塞栓術（TARE）、選択的内部放射線治療（SIRT）
  • 膵臓＆胆管がん治療薬の世界市場 2022年-2026年
  • 腫瘍溶解性ウイルス薬物治療の世界市場2023年：フェーズ1、フェーズ2、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA6458 )"膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他" (英文：Global Pancreatic Cancer Metastasis Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。